Covid-19: See latest data on suppliers and inventory

REGENERON PHARMACEUTICALS logo

REGENERON PHARMACEUTICALS

PSF Verified
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States
Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept injection for subcutaneous use; ZALTR...
DUNS #:
194873139
CAGE Code:
544P9
Type:
Manufacturer
Employees:
5,000-10,000
Annual Revenue:
$1B-$10B
Year Founded:
1988
Country of Origin:
United States
Sectors Served:
US Federal, US State, US Local, Private Sector, Non-US Public Sector
Company Security Level:
Unknown
Credit Card Usage:
Unknown

Specialties and Expertise:

Biopharma, Biotechnology, Pharmaceutical, Cardiovascular, Metabolic Disorders, Diseases, Inflammation, Immunology, Oncology, Immuno-Oncology, Antibody Drug Conjugates (ADCs), Anti-Vascular Endothe...

COVID-19 Supplies1

Are you making PPE or ventilators for COVID-19?
Let us know
Categories
Products Available
Inventory/Capacity
Certification
Available Contracts
Contact Info
Vaccines and Therapeutics
Kevzara
no data
no data
no data
no data

Contact Info4

Size and minority status

Size
Other than small business
Ownership
African American
Alaska Native
Asian-Indian
Asian-Pacific
Hispanic
Minority-Unspecified
Native American
Native Hawaiian
Tribal
Unspecified
Veteran
Woman
Government Set-Aside Programs
AbilityOne
HUBZone
SBA 8(a)
SDVOSB
Small Disadvantaged Business (SDB)
Woman Owned Small Business (WOSB)

Commodity Codes5

PRODUCTS AND SERVICES4

VelocImmune
2 past experiences
VelocImmune creates optimized antibody drug candidates from immunized mice and produces fully human antibodies therapeutics.
VelociT technology
1 past experience
VelociT technology is used for the production of fully human therapeutic T-cell receptors (TCR) against tumor and viral antigens.
Regeneron Genetics Center
Regeneron Genetics Center is an integrated large-scale genomics program that uses DNA sequencing and analysis to discover and develop drugs for the treatment of rare diseases.
Kevzara
1 past experience
Kevzara is a fully-human monoclonal antibody for rheumatoid arthritis that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor. The med is on clinical trails to combat Covid-19 coronavirus infection.

Past experience3

other
Kevzara to treat severe Covid-19
Sanofi and Regeneron Pharmaceuticals have started a clinical trial program evaluating Kevzara a rheumatoid arthritis drug to treat h...
other
Antibodies Discovery, Development and Produ...
HHS and Regeneron signed an agreement in 2017 to discover, research, develop and manufacture antibodies targeting up to ten pathogen...
other
Ebola Outbreak Antibody Therapeutic
VelocImmune technology previously leveraged to develop a three-antibody therapeutic to fight against the Ebola outbreak in the Democ...

Existing Contracts1

Contract Vehicle Type
Contract Name
Contract #
Who Can Use
Managing Organization
Exp. Date
no data
no data
V797D-50416
Federal
US General Services Administration (GSA)
Jul 14, 2020

External Recognition1

Top employers 2017
The Science Top Employer survey named Regeneron #1 employer in the global biopharmaceutical indus...
2017

Locations served1

  • United States 1 location
My Notes
Contact
My Notes